CAPTRUST Financial Advisors
MIRA icon

CAPTRUST Financial Advisors’s MIRA Pharmaceuticals MIRA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.6K Hold
90,645
– – ﹤0.01% 3195
2026
Q2 		$85.8K Buy
+90,645
New +$91.7K ﹤0.01% 3067

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
CSI
Cross Staff Investments Pittsford, New York $168M AUM 14.41% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
First American Bank
First American Bank Dundee, Illinois $1.81B AUM 24.18% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

CAPTRUST Financial Advisors's MIRA Position: Q3 2026 in Review

CAPTRUST Financial Advisors held its MIRA Pharmaceuticals (MIRA) position steady in Q3 2026 at 90,645 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

CAPTRUST Financial Advisors first reported a position in MIRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $85.8K in Q2 2026. 18 funds tracked by Wall St. Rank hold MIRA as of Q3 2026.

  • CAPTRUST Financial Advisors held 90,645 shares of MIRA Pharmaceuticals worth $76.6K as of Q3 2026.
  • CAPTRUST Financial Advisors left its MIRA Pharmaceuticals share count unchanged in Q3 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3195 holding.
  • CAPTRUST Financial Advisors first reported a position in MIRA Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • CAPTRUST Financial Advisors's MIRA Pharmaceuticals position peaked at $85.8K in Q2 2026.
  • 18 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.